Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom

被引:45
作者
Langman, M
Kahler, KAH
Kong, SX
Zhang, QY
Finch, E
Bentkover, JD
Stewart, EJ
机构
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Merck & Co Inc, Whitehouse Stn, NJ USA
[3] Innovat Hlth Solut, Brookline, MA USA
关键词
anti-inflammatory agents; non-steroidal; switching; drug utilization;
D O I
10.1002/pds.653
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To examine the frequency and determinants of switching between different non-steroidal anti-inflammatory drugs (NSAIDs) and the relationship with co-prescription of gastro-protective drugs (GPDs). Design This was an analysis of 30 654 patients receiving a total of 209 140 NSAID prescriptions in the UK from 1 January 1997 to 31 December 1998 identified through the MediPlus database. Analyses examined switching, repeat, termination and GPD co-prescription rates in new and continuing takers according to age and sex. Results Each patient received an average of 6.8 prescriptions in the year of study. Of the prescriptions 72.2% were for one of three NSAIDs, ibuprofen, diclofenac, or naproxen, and 7.2% of prescriptions were for fixed combination products of an NSAID plus a gastroprotective drug. At least 16.0% of continuing takers, and 28.5% of new takers switched to another NSAID in the review period. On average, new patients switched more frequently than continuing patients (0.39 switches/patient/year versus 0.23 switches/patient/year, p<0.001). Switching between NSAIDs decreased with age and was less common in women (p<0.05). Switching was associated with a 24% and 33% increased probability of GPD prescription in new and continuing takers, respectively. Discussion The frequency of switching, and of GPD co-prescription at switching, suggest that dissatisfaction with NSAIDs is frequent, and that gastrointestinal intolerance is a common feature of this dissatisfaction. Copyright (C) 2001 John Wiley Sons, Ltd.
引用
收藏
页码:517 / 524
页数:8
相关论文
共 23 条
[1]   UTILIZATION OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
BAUM, C ;
KENNEDY, DL ;
FORBES, MB .
ARTHRITIS AND RHEUMATISM, 1985, 28 (06) :686-692
[2]   AN EQUILIBRIUM-MODEL OF DRUG UTILIZATION [J].
CHAN, KWA ;
WALKER, AM ;
YOOD, RA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (01) :113-121
[3]  
FRIES JF, 1991, J RHEUMATOL, V18, P6
[4]   RISK FOR SERIOUS GASTROINTESTINAL COMPLICATIONS RELATED TO USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A METAANALYSIS [J].
GABRIEL, SE ;
JAAKKIMAINEN, L ;
BOMBARDIER, C .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :787-796
[5]  
HENRY D, 1996, BMJ-BRIT MED J, V312, P1653
[6]  
*IMS HLTH, 1998, UK PRIM CAR DAT QUAL
[7]   DISCONTINUATION OF AND CHANGES IN TREATMENT AFTER START OF NEW COURSES OF ANTIHYPERTENSIVE DRUGS - A STUDY OF A UNITED-KINGDOM POPULATION [J].
JONES, JK ;
GORKIN, L ;
LIAN, JF ;
STAFFA, JA ;
FLETCHER, AP .
BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7000) :293-295
[8]   RISKS OF BLEEDING PEPTIC-ULCER ASSOCIATED WITH INDIVIDUAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
LANGMAN, MJS ;
WEIL, J ;
WAINWRIGHT, P ;
LAWSON, DH ;
RAWLINS, MD ;
LOGAN, RFA ;
MURPHY, M ;
VESSEY, MP ;
COLINJONES, DG .
LANCET, 1994, 343 (8905) :1075-1078
[9]  
LAWRENSON RA, 1998, J INFORMATICS PR MAY, P14
[10]  
LLOYD CEF, 1997, BMJ-BRIT MED J, V311, P991